3-Chloro-2-cyanopyridine

We are 3-Chloro-2-cyanopyridine CAS:38180-46-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-Chloro-2-cyanopyridine
CAS.NO:38180-46-0
Synonyms:3-Chloro-2-cyanopyridine
3-Chloro-2-pyridinecarbonitrile
2-Cyano-3-Chloropyridine
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 260.7±20.0 °C at 760 mmHg
Melting Point 81-83°C
Molecular Formula C6H3ClN2
Molecular Weight 138.554
Flash Point 111.4±21.8 °C
 
Specification:
Appearance:Yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

3-Chloro-2-cyanopyridine


Related News: At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content.N-Boc-L-tert-Leucina CAS:62965-35-9 At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content.resorcinol CAS:108-46-3 As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.Ethyl 2,6-Dichloro-5-Fluoro-Pyridine-3-Acetoacetate CAS:96568-04-6 As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.

Related Products
Product Name
methyl (1R,2S)-1-amino-2-ethenylcyclopropane-1-carboxylate,hydrochloride View Details
(3R)-3-<(tert-Butyldimethylsilyl)oxy>pentanedioic acid 1-<(R)-mandelic acid> ester View Details
1-Methyl-4-piperidone View Details
4-chloropyridin-2-amine manufacturer 4-Sulfonamide-phenylhydrazine hydrochloride manufacturer 5-Fluoro-2-methylbenzoic acid manufacturer (3S,4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-3-hydroxy-6-methylheptanoic acid manufacturer 2-chloro-N-methyl-3-oxobutanamide manufacturer